Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stelara
Pharma
J&J leans on oncology growth drivers as Stelara sales slow
The company picked up a record $3 billion in quarterly sales for its multiple myeloma powerhouse Darzalex.
Zoey Becker
Oct 15, 2024 11:45am
Lilly's Omvoh bests J&J's Stelara in Crohn's study
Oct 14, 2024 12:15pm
J&J ushers in new 340B rebate policy for Stelara, Xarelto
Aug 26, 2024 11:23am
Samsung Biologics' 37% sales surge propelled by biosimilars
Jul 24, 2024 10:56am
Subcutaneous version of J&J's Tremfya excels in Crohn's trial
Jun 20, 2024 11:12am
Colorado drug review board finds J&J's Stelara unaffordable
Jun 11, 2024 9:05am
